MontanaMontana would limit state purchases of opioid reversal drugs
Montana would stop using state and available federal money for certain opioid reversal drug purchases, while allowing some existing supply promises to continue.
What it does
Starting July 1, 2025, Montana could not use state or available federal money to buy opioid reversal drugs from companies tied to certain state opioid settlements. Some existing contracts and settlement supply promises could continue until their terms are fulfilled, but covered state contracts could not be renewed after June 30, 2025.
Argument forThe restriction could keep public money from going to companies tied to state opioid settlements while allowing some existing supply promises to continue.
Argument againstAgencies could have fewer suppliers to choose from after covered contracts end, which might make it harder to keep buying these drugs.
More detail
The proposal would bar state agencies from using state or available federal money to buy opioid reversal drugs from certain companies. It would cover companies that were party to a state settlement over making, selling, or distributing prescription opioids, and their affiliates and subsidiaries. The restriction would not apply to a supplier with a state contract signed before July 1, 2025, until that contract's terms are fulfilled. A covered state contract could not be renewed after June 30, 2025. A supplier that agreed to provide the state with these drugs under a settlement made before September 1, 2024, would have to keep supplying them until the settlement terms are fulfilled. The proposal says it would take effect upon passage and approval. The purchase restriction would apply after June 30, 2025.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Died
Looking ahead
No hearings or votes scheduled.
History
- 2025
- May 23(H) Died in CommitteeDied
- Feb 18(H) Tabled in Committee - (H) Human ServicesMinor
- Vote recorded to_table. Result: pass.Lower
- Feb 7(H) Hearing - (H) Human Services
- Feb 5(H) 1st Reading
- Feb 5(H) Referred to Committee - (H) Human ServicesMinor
- Feb 4(S) Transmitted to House
- Vote recorded Do Pass. Result: pass.Upper
- Feb 4(S) 3rd Reading
- Feb 4(S) Scheduled for 3rd ReadingMinor
- Feb 3(S) 2nd ReadingMinor
- Vote recorded Do Pass. Result: pass.Upper
- Feb 3(S) Scheduled for 2nd ReadingMinor
- Jan 30(S) Committee Report - (S) Public Health, Welfare and Safety
- Jan 29(S) Committee Executive Action - (S) Public Health, Welfare and Safety
- Vote recorded do_pass. Result: pass.Upper
- Jan 15(S) Hearing - (S) Public Health, Welfare and Safety
- Jan 14(S) Referred to Committee - (S) Public Health, Welfare and SafetyMinor
- Jan 9(S) 1st Reading
- Jan 8(S) Introduced
- Jan 8(LC) Draft Delivered to Requester
- Jan 8(LC) Draft Ready for Delivery
- Jan 6(LC) Draft in Assembly
- Jan 5(LC) Draft in Final Drafter Review
- Jan 3(LC) Draft in Input/Proofing
- Jan 1(LC) Draft in Edit
- Jan 1(LC) Draft in Legal Review
- 2024
- Nov 29(LC) Drafter AssignedIntroduced
Healthcare